Description

IGF-1 LR3 1mg is a research-grade analogue of insulin-like growth factor-1 (IGF-1), developed for scientific investigation into cellular growth, differentiation, and metabolic signalling pathways. This modified variant contains an extended amino acid sequence and structural changes that increase stability and extend biological activity compared with standard IGF-1, making it widely used in advanced biochemical and molecular research models.

Due to its enhanced resistance to binding proteins and longer half-life, IGF-1 LR3 is frequently explored in laboratory studies examining cell proliferation, protein synthesis pathways, and growth factor signalling mechanisms. These characteristics make it valuable for controlled experiments focused on endocrine signalling, metabolic responses, and cellular development processes.

Each vial contains 1mg of high-purity IGF-1 LR3 supplied as a lyophilised peptide powder, manufactured under strict quality control standards to ensure consistency, stability, and accuracy in professional research environments. The lyophilised format allows researchers to reconstitute the peptide as required for specific experimental protocols.